BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved our understanding of the immunopathogenesis of lymphoid tumors. Early B-lymphocyte precursors of multiple myeloma are known to exist and might be susceptible to antigenic drive. DESIGN AND METHODS: To verify this hypothesis, we collected a database of 345 fully readable multiple myeloma immunoglobulin sequences. We characterized the immunoglobulin repertoire, analyzed the somatic hypermutation load, and investigated for stereotyped receptor clusters. RESULTS: Compared to the normal immunoglobulin repertoire, multiple myeloma displayed only modest differences involving only a few genes, showing that the myeloma immunoglobulin repertoire is the least skewed among mature B-cell tumors. Median somatic hypermutation load was 7.8%; median length of complementarity determining-region 3 was 15.5 amino acids. Clustering analysis showed the absence of myeloma specific clusters and no similarity with published chronic lymphocytic leukemia or lymphoma subsets. CONCLUSIONS: Analysis of multiple myeloma immunoglobulin repertoire does not support a pathogenetic role for antigen selection in this tumor.
BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved our understanding of the immunopathogenesis of lymphoid tumors. Early B-lymphocyte precursors of multiple myeloma are known to exist and might be susceptible to antigenic drive. DESIGN AND METHODS: To verify this hypothesis, we collected a database of 345 fully readable multiple myeloma immunoglobulin sequences. We characterized the immunoglobulin repertoire, analyzed the somatic hypermutation load, and investigated for stereotyped receptor clusters. RESULTS: Compared to the normal immunoglobulin repertoire, multiple myeloma displayed only modest differences involving only a few genes, showing that the myeloma immunoglobulin repertoire is the least skewed among mature B-cell tumors. Median somatic hypermutation load was 7.8%; median length of complementarity determining-region 3 was 15.5 amino acids. Clustering analysis showed the absence of myeloma specific clusters and no similarity with published chronic lymphocytic leukemia or lymphoma subsets. CONCLUSIONS: Analysis of multiple myeloma immunoglobulin repertoire does not support a pathogenetic role for antigen selection in this tumor.
Authors: David González; Marcos González; Ana Balanzategui; Maria E Sarasquete; Ricardo López-Pérez; M Carmen Chillón; Ramón García-Sanz; Jesús F San Miguel Journal: Haematologica Date: 2005-07 Impact factor: 9.941
Authors: R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi Journal: Blood Date: 1999-09-15 Impact factor: 22.113
Authors: F Fais; F Ghiotto; S Hashimoto; B Sellars; A Valetto; S L Allen; P Schulman; V P Vinciguerra; K Rai; L Z Rassenti; T J Kipps; G Dighiero; H W Schroeder; M Ferrarini; N Chiorazzi Journal: J Clin Invest Date: 1998-10-15 Impact factor: 14.808
Authors: David González; Mirjam van der Burg; Ramón García-Sanz; James A Fenton; Anton W Langerak; Marcos González; Jacques J M van Dongen; Jesus F San Miguel; Gareth J Morgan Journal: Blood Date: 2007-07-18 Impact factor: 22.113
Authors: Daniel Mazza Matos; Ana Cesarina Vitoriano de Oliveira; Maria de Nazaré Amaral Tomé; Carlos Alberto Scrideli Journal: Med Oncol Date: 2012-06-12 Impact factor: 3.064
Authors: M Ladetto; M Brüggemann; L Monitillo; S Ferrero; F Pepin; D Drandi; D Barbero; A Palumbo; R Passera; M Boccadoro; M Ritgen; N Gökbuget; J Zheng; V Carlton; H Trautmann; M Faham; C Pott Journal: Leukemia Date: 2013-12-17 Impact factor: 11.528
Authors: Alejandro Medina; Cristina Jiménez; M Eugenia Sarasquete; Marcos González; M Carmen Chillón; Ana Balanzategui; Isabel Prieto-Conde; María García-Álvarez; Noemí Puig; Verónica González-Calle; Miguel Alcoceba; Isabel Cuenca; Santiago Barrio; Fernando Escalante; Norma C Gutiérrez; Mercedes Gironella; Miguel T Hernández; Anna Sureda; Albert Oriol; Joan Bladé; Juan-José Lahuerta; Jesús F San Miguel; María-Victoria Mateos; Joaquín Martínez-López; María-José Calasanz; Ramón García-Sanz Journal: Blood Cancer J Date: 2020-02-06 Impact factor: 11.037